From the Fresh Facial Aesthetic Surgery and ENT Clinic; Yonsei E1 Plastic Surgery Clinic; Maylin Clinic; Yonsei Seran Dermatology and Laser Clinic; and the Department of Plastic and Reconstructive Surgery, Yonsei University, College of Medicine.
Plast Reconstr Surg. 2021 Mar 1;147(3):401e-411e. doi: 10.1097/PRS.0000000000007623.
Autologous adipose-derived stromal vascular fraction treatments have been shown to elicit antiinflammatory, antifibrotic, immunomodulatory, angiogenic, and regenerative effects. Injections of adipose-derived stromal vascular fraction have been used to treat severely scarred tissues.
Revision septorhinoplasty was performed in 40 patients with severely contracted noses. Clinical outcomes and adverse events were compared between one group of patients treated with adjuvant adipose-derived stromal vascular fraction injections and a control group of patients treated with adjuvant 0.9% preservative-free saline injections.
In the adipose-derived stromal vascular fraction group, nasal lengths were estimated at 4.2 ± 0.2 cm at baseline to 5.1 ± 0.2 cm at 18 months after revision septorhinoplasty. The lengths of nasal tip projection improved from 2.2 ± 0.2 cm at baseline to 2.9 ± 0.1 cm 18 months after surgery. In addition, nasofrontal angles improved from 125.6 ± 5.1 degrees at baseline to 128.1 ± 4.8 degrees 18 months after surgery. Nasolabial angles in the adipose-derived stromal vascular fraction group were estimated at 105.8 ± 6.5 degrees at baseline and 94.9 ± 5.6 degrees 18 months after surgery. Of these, nasal length, nasal tip projection, and nasolabial angle, but not nasofrontal angle, values improved more in the adipose-derived stromal vascular fraction group than in the control group.
Preoperative and postoperative adjuvant adipose-derived stromal vascular fraction treatment markedly improved the therapeutic outcomes of revision rhinoseptoplasty of severely contracted noses without major side effects.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
自体脂肪来源的基质血管成分治疗已显示出抗炎、抗纤维化、免疫调节、血管生成和再生作用。脂肪来源的基质血管成分注射已被用于治疗严重瘢痕组织。
对 40 例严重挛缩鼻患者进行了 Revision 鼻中隔成形术。比较了一组接受辅助脂肪来源基质血管成分注射治疗的患者和一组接受辅助 0.9%无防腐剂生理盐水注射治疗的患者的临床结果和不良事件。
在脂肪来源基质血管成分组中,鼻长度从基线时的 4.2 ± 0.2cm 估计为 18 个月时的 5.1 ± 0.2cm。鼻尖突出度从基线时的 2.2 ± 0.2cm 改善至术后 18 个月时的 2.9 ± 0.1cm。此外,鼻额角从基线时的 125.6 ± 5.1 度改善至术后 18 个月时的 128.1 ± 4.8 度。脂肪来源基质血管成分组的鼻唇角在基线时估计为 105.8 ± 6.5 度,术后 18 个月时为 94.9 ± 5.6 度。其中,脂肪来源基质血管成分组的鼻长度、鼻尖突出度和鼻唇角值改善程度大于对照组,而鼻额角值改善程度无统计学差异。
术前和术后辅助脂肪来源基质血管成分治疗显著改善了严重挛缩鼻 Revision 鼻中隔成形术的治疗效果,且无明显副作用。
临床问题/证据水平:治疗,III 级。